- Home
- VFF vs GALT Comparison
VFF vs GALT Comparison
Compare VFF & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFF
- GALT
- Stock Information
- Founded
- VFF 1989
- GALT 2000
- Country
- VFF United States
- GALT United States
- Employees
- VFF N/A
- GALT N/A
- Industry
- VFF
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- VFF
- GALT Health Care
- Exchange
- VFF Nasdaq
- GALT Nasdaq
- Market Cap
- VFF 79.3M
- GALT 86.0M
- IPO Year
- VFF N/A
- GALT N/A
- Fundamental
- Price
- VFF $0.67
- GALT $1.38
- Analyst Decision
- VFF Buy
- GALT Hold
- Analyst Count
- VFF 1
- GALT 1
- Target Price
- VFF N/A
- GALT N/A
- AVG Volume (30 Days)
- VFF 365.4K
- GALT 177.7K
- Earning Date
- VFF 05-12-2025
- GALT 05-19-2025
- Dividend Yield
- VFF N/A
- GALT N/A
- EPS Growth
- VFF N/A
- GALT N/A
- EPS
- VFF N/A
- GALT N/A
- Revenue
- VFF $336,181,000.00
- GALT N/A
- Revenue This Year
- VFF $2.43
- GALT N/A
- Revenue Next Year
- VFF $8.99
- GALT N/A
- P/E Ratio
- VFF N/A
- GALT N/A
- Revenue Growth
- VFF 17.71
- GALT N/A
- 52 Week Low
- VFF $0.45
- GALT $0.73
- 52 Week High
- VFF $1.48
- GALT $3.41
- Technical
- Relative Strength Index (RSI)
- VFF 52.44
- GALT 49.81
- Support Level
- VFF $0.70
- GALT $1.26
- Resistance Level
- VFF $0.74
- GALT $1.63
- Average True Range (ATR)
- VFF 0.04
- GALT 0.13
- MACD
- VFF -0.00
- GALT 0.02
- Stochastic Oscillator
- VFF 44.36
- GALT 37.50
About VFF Village Farms International Inc.
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.